Suppr超能文献

微小RNA-338-3p通过靶向叉头框P4(FOXP4)抑制肝细胞癌中的细胞增殖。

MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).

作者信息

Wang Gang, Sun Yubei, He Yifu, Ji Chushu, Hu Bing, Sun Yuping

机构信息

Department of Oncology, Jinan Central Hospital, Shandong University Jinan 250013, Shandong, China ; Department of Oncology, Anhui Medical University Affiliated Anhui Provincial Hospital Hefei 230000, Anhui, China.

Department of Oncology, Anhui Medical University Affiliated Anhui Provincial Hospital Hefei 230000, Anhui, China.

出版信息

Int J Clin Exp Pathol. 2015 Jan 1;8(1):337-44. eCollection 2015.

Abstract

MicroRNAs (miRNAs) are a class of small, non-coding RNAs, which have demonstrated to important gene regulators, and have critical roles in diverse biological processes including cancer cell proliferation. Previous studies suggested microRNA-338-3p (miR-338-3p) was down-regulated and play tumor suppressor roles in gastric cancer, colorectal carcinoma and lung cancer. However, the role of miR-338-3p in hepatocellular carcinoma (HCC) is still unclear. In this study, we analyzed the expression of miR-338-3p in HCC tissues and HCC cell lines. We find that miR-338-3p was downregulated in HCC tissues and cell lines. Then functional studies demonstrate ectopic miR-338-3p expression significantly suppressed the in vitro proliferation and colony formation of HCC cells and cause to cell cycle arrest. Using bio-informatic method and report assay we identified a novel miR-338-3p target, FOXP4 in HCC cells. Furthermore, knockdown of FOXP4 have the similar effects in HCC corrected with miR-338-3p. These findings suggest that miR-338-3p regulates survival of HCC cells partially through the downregulation of FOXP4. Therefore, targeting with the miR-338-3p/FOXP4 axis might serve as a novel therapeutic application to treat HCC patients.

摘要

微小RNA(miRNA)是一类小的非编码RNA,已被证明是重要的基因调节因子,在包括癌细胞增殖在内的多种生物学过程中发挥关键作用。先前的研究表明,微小RNA-338-3p(miR-338-3p)在胃癌、结直肠癌和肺癌中表达下调并发挥肿瘤抑制作用。然而,miR-338-3p在肝细胞癌(HCC)中的作用仍不清楚。在本研究中,我们分析了miR-338-3p在HCC组织和HCC细胞系中的表达。我们发现miR-338-3p在HCC组织和细胞系中表达下调。随后的功能研究表明,异位表达miR-338-3p可显著抑制HCC细胞的体外增殖和集落形成,并导致细胞周期停滞。使用生物信息学方法和报告分析,我们在HCC细胞中鉴定出一个新的miR-338-3p靶标FOXP4。此外,敲低FOXP4在HCC中具有与miR-338-3p类似的作用。这些发现表明,miR-338-3p部分通过下调FOXP4来调节HCC细胞的存活。因此,靶向miR-338-3p/FOXP4轴可能成为治疗HCC患者的一种新的治疗方法。

相似文献

3
MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
Biomed Pharmacother. 2018 Mar;99:817-824. doi: 10.1016/j.biopha.2018.01.131. Epub 2018 Feb 20.
4
miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
Tumour Biol. 2016 Feb;37(2):2497-507. doi: 10.1007/s13277-015-4071-1. Epub 2015 Sep 18.
5
MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
J Cell Mol Med. 2019 Aug;23(8):5037-5047. doi: 10.1111/jcmm.14361. Epub 2019 Jun 17.
7
MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
J Cancer Res Clin Oncol. 2017 Feb;143(2):263-273. doi: 10.1007/s00432-016-2280-7. Epub 2016 Oct 4.
8
miR-874-3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression.
Oncotarget. 2017 Feb 14;8(7):11343-11355. doi: 10.18632/oncotarget.14526.
10
Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
Eur Rev Med Pharmacol Sci. 2019 Aug;23(16):6888-6898. doi: 10.26355/eurrev_201908_18728.

引用本文的文献

2
Incomplete Thermal Ablation-Induced FOXP4-Mediated Promotion of Malignant Progression in Liver Cancer via NDST2.
J Hepatocell Carcinoma. 2024 Oct 14;11:1945-1959. doi: 10.2147/JHC.S476612. eCollection 2024.
4
Role of microRNA-363 during tumor progression and invasion.
J Physiol Biochem. 2024 Aug;80(3):481-499. doi: 10.1007/s13105-024-01022-1. Epub 2024 May 1.
5
microRNA-338-3p suppresses lipopolysaccharide-induced inflammatory response in HK-2 cells.
BMC Mol Cell Biol. 2022 Dec 23;23(1):60. doi: 10.1186/s12860-022-00455-0.
6
Effect of FOXP2 transcription factor on immune infiltration of thyroid cancer and its potential clinical value.
Front Immunol. 2022 Sep 20;13:982812. doi: 10.3389/fimmu.2022.982812. eCollection 2022.
8
Combined analyses of RNA-sequence and Hi-C along with GWAS loci-A novel approach to dissect keloid disorder genetic mechanism.
PLoS Genet. 2022 Jun 16;18(6):e1010168. doi: 10.1371/journal.pgen.1010168. eCollection 2022 Jun.
10
Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2.
Cell Death Differ. 2022 Jan;29(1):82-95. doi: 10.1038/s41418-021-00838-4. Epub 2021 Jul 22.

本文引用的文献

2
miR-1285-3p acts as a potential tumor suppressor miRNA via downregulating JUN expression in hepatocellular carcinoma.
Tumour Biol. 2015 Jan;36(1):219-25. doi: 10.1007/s13277-014-2622-5. Epub 2014 Sep 18.
3
Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.
PLoS One. 2013 Jun 24;8(6):e66782. doi: 10.1371/journal.pone.0066782. Print 2013.
4
miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened.
World J Gastroenterol. 2013;19(14):2197-207. doi: 10.3748/wjg.v19.i14.2197.
5
Foxp4 is dispensable for T cell development, but required for robust recall responses.
PLoS One. 2012;7(8):e42273. doi: 10.1371/journal.pone.0042273. Epub 2012 Aug 13.
7
Hepatocellular carcinoma: focus on different aspects of management.
ISRN Oncol. 2012;2012:421673. doi: 10.5402/2012/421673. Epub 2012 May 13.
8
Hepatocellular carcinoma.
Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20.
9
miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.
J Pathol. 2011 Nov;225(3):463-72. doi: 10.1002/path.2877. Epub 2011 Jun 13.
10
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a.
Gastroenterology. 2011 May;140(5):1618-28.e16. doi: 10.1053/j.gastro.2011.02.009. Epub 2011 Feb 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验